BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 8652510)

  • 1. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
    Mitchell EP; Withers SG; Ermert P; Vasella AT; Garman EF; Oikonomakos NG; Johnson LN
    Biochemistry; 1996 Jun; 35(23):7341-55. PubMed ID: 8652510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.
    Leonidas DD; Oikonomakos NG; Papageorgiou AC; Acharya KR; Barford D; Johnson LN
    Protein Sci; 1992 Sep; 1(9):1112-22. PubMed ID: 1304390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined crystal structure of the phosphorylase-heptulose 2-phosphate-oligosaccharide-AMP complex.
    Johnson LN; Acharya KR; Jordan MD; McLaughlin PJ
    J Mol Biol; 1990 Feb; 211(3):645-61. PubMed ID: 2106586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.
    Johnson LN; Snape P; Martin JL; Acharya KR; Barford D; Oikonomakos NG
    J Mol Biol; 1993 Jul; 232(1):253-67. PubMed ID: 8331662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies.
    Oikonomakos NG; Zographos SE; Johnson LN; Papageorgiou AC; Acharya KR
    J Mol Biol; 1995 Dec; 254(5):900-17. PubMed ID: 7500360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
    Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
    Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.
    Oikonomakos NG; Zographos SE; Tsitsanou KE; Johnson LN; Acharya KR
    Protein Sci; 1996 Dec; 5(12):2416-28. PubMed ID: 8976550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
    Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
    Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
    Oikonomakos NG; Tiraidis C; Leonidas DD; Zographos SE; Kristiansen M; Jessen CU; Nørskov-Lauritsen L; Agius L
    J Med Chem; 2006 Sep; 49(19):5687-701. PubMed ID: 16970395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
    Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
    Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
    Oikonomakos NG; Kontou M; Zographos SE; Watson KA; Johnson LN; Bichard CJ; Fleet GW; Acharya KR
    Protein Sci; 1995 Dec; 4(12):2469-77. PubMed ID: 8580837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs.
    Tebbe J; Bzowska A; Wielgus-Kutrowska B; Schröder W; Kazimierczuk Z; Shugar D; Saenger W; Koellner G
    J Mol Biol; 1999 Dec; 294(5):1239-55. PubMed ID: 10600382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
    Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
    J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.
    Rath VL; Ammirati M; LeMotte PK; Fennell KF; Mansour MN; Danley DE; Hynes TR; Schulte GK; Wasilko DJ; Pandit J
    Mol Cell; 2000 Jul; 6(1):139-48. PubMed ID: 10949035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
    Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
    Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
    Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-cofactor interactions for glycogen phosphorylase b: a binding study in the crystal with heptenitol and heptulose 2-phosphate.
    McLaughlin PJ; Stuart DI; Klein HW; Oikonomakos NG; Johnson LN
    Biochemistry; 1984 Nov; 23(24):5862-73. PubMed ID: 6441595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the ternary complex of E. coli purine nucleoside phosphorylase with formycin B, a structural analogue of the substrate inosine, and phosphate (Sulphate) at 2.1 A resolution.
    Koellner G; Luić M; Shugar D; Saenger W; Bzowska A
    J Mol Biol; 1998 Jul; 280(1):153-66. PubMed ID: 9653038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
    Watson KA; Chrysina ED; Tsitsanou KE; Zographos SE; Archontis G; Fleet GW; Oikonomakos NG
    Proteins; 2005 Dec; 61(4):966-83. PubMed ID: 16222658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
    Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.